Trial Profile
A Study Assessing The Effect Of Cobicistat Versus Ritonavir On Darunavir And Dolutegravir Exposure In HIV-Infected Patients Switching From Darunavir/Ritonavir To Darunavir/Cobicistat With Dolutegravir Given As Part Of Their Antiretroviral Therapy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Apr 2017
Price :
$35
*
At a glance
- Drugs Cobicistat/darunavir (Primary) ; Dolutegravir (Primary) ; Darunavir/ritonavir
- Indications HIV infections
- Focus Adverse reactions; Pharmacokinetics
- 06 Apr 2017 New trial record
- 16 Feb 2017 Results presented at the 24th Conference on Retroviruses and Opportunistic Infections.